The document discusses Aegate's role in providing services related to the European Union's Falsified Medicines Directive. It outlines Aegate's selection to provide national blueprint systems for verification across Europe. It invites partners to join Aegate's ecosystem partner programme to gain access to information, best practices, and opportunities to benefit from Aegate's revenue sharing and certification programmes for pharmacies and software providers across Europe.